DiaMedica Therapeutics (DMAC) Non-Current Assets (2017 - 2026)
DiaMedica Therapeutics (DMAC) reported Non-Current Assets of $717000.0 for Q1 2026, down 49.08% on a YoY basis from $1.4 million in Q1 2025, and down 3.37% quarter-over-quarter from $742000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Non-Current Assets (2017 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Non-Current Assets for 10 years, with the latest figure at $717000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 49.08% year-over-year to $717000.0; the trailing twelve-month figure through Mar 2026 stood at $717000.0 (down 49.08% YoY), and the FY2025 full-year result was $742000.0, down 57.23% from the prior year.
- Non-Current Assets for Q1 2026 stood at $717000.0, down from $742000.0 in the prior quarter.
- The five-year high for Non-Current Assets was $20.8 million in Q2 2023, with the low at $85000.0 in Q2 2022.
- Historically, Non-Current Assets has averaged $2.6 million across 5 years, with a median of $742000.0 in 2025.
- Annual changes were most pronounced in 2023 — Non-Current Assets soared 24392.94% — and 2024, when it slumped 91.46%.
- DiaMedica Therapeutics' Non-Current Assets stood at $560000.0 in 2022, then declined by 13.39% to $485000.0 in 2023, then surged by 257.73% to $1.7 million in 2024, then slumped by 57.23% to $742000.0 in 2025, then retreated by 3.37% to $717000.0 in 2026.
- The last three Non-Current Assets figures came in at $717000.0 (Q1 2026), $742000.0 (Q4 2025), and $824000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 62,953.78 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 39.71 Mn |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | 717,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 717,000.00 |
| Dec 31, 2025 | 742,000.00 |
| Sep 30, 2025 | 824,000.00 |
| Jun 30, 2025 | 391,000.00 |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 485,000.00 |
| Sep 30, 2023 | 10.25 Mn |
| Jun 30, 2023 | 20.82 Mn |
| Mar 31, 2023 | 543,000.00 |
| Dec 31, 2022 | 560,000.00 |
| Sep 30, 2022 | 551,000.00 |
| Jun 30, 2022 | 85,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Sep 30, 2021 | 127,000.00 |
| Jun 30, 2021 | 145,000.00 |